Literature DB >> 17588661

The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling.

Yelina Alvarez1, Xiaobin Tang, John E Coligan, Francisco Borrego.   

Abstract

To achieve an adequate response, cells of the immune system must be tightly regulated to avoid hypo or hyper responsiveness. One of the mechanisms used by the immune system to avoid excessive inflammation is the modulation of the response through inhibitory receptors containing immunoreceptor tyrosine based inhibitory motifs (ITIM). Here, we show that human neutrophils from peripheral blood express the ITIM containing CD300a (also known as IRp60 and CMRF-35H) receptor. By using the HL-60 differentiation model, we show that the expression of CD300a receptor is developmentally regulated. Stimulation of human neutrophils with LPS and GM-CSF increased the cell surface expression of CD300a as a result of the rapid translocation of an intracellular pool of the receptor to the cell surface. Co-ligation of CD300a with the immunoreceptor tyrosine based activating motif (ITAM) containing CD32a (FcgammaRIIa) activation receptor inhibited CD32a mediated signalling; whereas, it did not inhibit toll-like receptor (TLR)-4 mediated reactive oxygen species (ROS) production. Therefore, at least for human neutrophils, the inhibitory signals mediated by the CD300a receptor may be selective in their action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588661      PMCID: PMC2000843          DOI: 10.1016/j.molimm.2007.05.006

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  28 in total

1.  Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a.

Authors:  Ido Bachelet; Ariel Munitz; Francesca Levi-Schaffer
Journal:  J Allergy Clin Immunol       Date:  2006-06       Impact factor: 10.793

Review 2.  Sorting out Toll signals.

Authors:  Katherine A Fitzgerald; Zhijian J Chen
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

3.  Neutrophils lacking platelet-endothelial cell adhesion molecule-1 exhibit loss of directionality and motility in CXCR2-mediated chemotaxis.

Authors:  Yue Wu; Paul Stabach; Michael Michaud; Joseph A Madri
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

Review 4.  Neutrophils and immunity: challenges and opportunities.

Authors:  Carl Nathan
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

5.  The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils.

Authors:  Ariel Munitz; Ido Bachelet; Ron Eliashar; Alessandro Moretta; Lorenzo Moretta; Francesca Levi-Schaffer
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

6.  The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells.

Authors:  Ido Bachelet; Ariel Munitz; Alessandro Moretta; Lorenzo Moretta; Francesca Levi-Schaffer
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

7.  Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a.

Authors:  Ariel Munitz; Ido Bachelet; Francesca Levi-Schaffer
Journal:  J Allergy Clin Immunol       Date:  2006-09-25       Impact factor: 10.793

Review 8.  Functional regulation of human neutrophil Fc gamma receptors.

Authors:  Periasamy Selvaraj; Nimita Fifadara; Shanmugam Nagarajan; Ashley Cimino; Guixian Wang
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

9.  Differential expression of leukocyte-associated Ig-like receptor-1 during neutrophil differentiation and activation.

Authors:  Annelies Verbrugge; Talitha de Ruiter; Christian Geest; Paul J Coffer; Linde Meyaard
Journal:  J Leukoc Biol       Date:  2006-02-03       Impact factor: 4.962

10.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  36 in total

1.  Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis.

Authors:  Yi Xu; Federica Tarquini; Roberto Romero; Chong Jai Kim; Adi L Tarca; Gaurav Bhatti; JoonHo Lee; I Birgitta Sundell; Pooja Mittal; Juan Pedro Kusanovic; Sonia S Hassan; Jung-Sun Kim
Journal:  Am J Reprod Immunol       Date:  2011-11-13       Impact factor: 3.886

2.  CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation.

Authors:  Agueda Martínez-Barriocanal; Emma Comas-Casellas; Simo Schwartz; Margarita Martín; Joan Sayós
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

3.  Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells.

Authors:  Venkateswara R Simhadri; John F Andersen; Eric Calvo; Seung-Chul Choi; John E Coligan; Francisco Borrego
Journal:  Blood       Date:  2012-02-01       Impact factor: 22.113

4.  Bruton's tyrosine kinase mediates FcγRIIa/Toll-like receptor-4 receptor crosstalk in human neutrophils.

Authors:  Agnieszka Krupa; Rafal Fudala; Jon M Florence; Torry Tucker; Timothy C Allen; Theodore J Standiford; Rafal Luchowski; Marek Fol; Moshiur Rahman; Zygmunt Gryczynski; Ignacy Gryczynski; Anna K Kurdowska
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-13       Impact factor: 6.914

Review 5.  The CD300 molecules: an emerging family of regulators of the immune system.

Authors:  Francisco Borrego
Journal:  Blood       Date:  2013-01-04       Impact factor: 22.113

6.  CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection.

Authors:  Rodolfo Silva; Susan Moir; Lela Kardava; Karen Debell; Venkateswara R Simhadri; Sara Ferrando-Martínez; Manuel Leal; José Peña; John E Coligan; Francisco Borrego
Journal:  Blood       Date:  2011-04-11       Impact factor: 22.113

7.  CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines.

Authors:  Eun-Ju Kim; Sang-Min Lee; Kyoungho Suk; Won-Ha Lee
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

8.  All-trans-retinoic acid and Erk1/2 signaling synergistically regulate the expression of CD300B in human monocytic cells.

Authors:  Yong Wu; Qiuyan Chen; Tongkun Pai; A Catharine Ross
Journal:  Cell Immunol       Date:  2011-03-29       Impact factor: 4.868

9.  Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition.

Authors:  Mariko Takahashi; Kumi Izawa; Jun-ichi Kashiwakura; Yoshinori Yamanishi; Yutaka Enomoto; Ayako Kaitani; Akie Maehara; Masamichi Isobe; Shinichi Ito; Toshihiro Matsukawa; Fumio Nakahara; Toshihiko Oki; Masunori Kajikawa; Chisei Ra; Yoshimichi Okayama; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

10.  Human Th1 cells that express CD300a are polyfunctional and after stimulation up-regulate the T-box transcription factor eomesodermin.

Authors:  Sriram Narayanan; Rodolfo Silva; Giovanna Peruzzi; Yelina Alvarez; Venkateswara R Simhadri; Karen Debell; John E Coligan; Francisco Borrego
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.